Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomic Zone of Safety of the Presacral Space.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Sustained Vaginal Stent Placement in the Surgical Management of Shortened Vaginal Length.

Obstetrics and gynecology·2025
Same author

Effects of Social Determinants of Health and Social Support on Surgical Outcomes Among Patients Undergoing Hysterectomy.

Obstetrics and gynecology·2024
Same author

Preoperative Simulation of Retropubic Midurethral Sling to Decrease Bladder Perforation Rate Among Obstetrics and Gynecology Residents.

Urogynecology (Philadelphia, Pa.)·2023
Same author

Risk Factors for Surgical Failure and Worsening Pelvic Floor Symptoms Within 5 Years After Vaginal Prolapse Repair.

Obstetrics and gynecology·2020
Same author

Prospective study of a single-incision sling versus a transobturator sling in women with stress urinary incontinence: 3-year results.

American journal of obstetrics and gynecology·2020
Same journal

Urinary and Bowel Symptoms Among Gay and Bisexual Prostate Cancer Survivors and Their Associations with Quality of Life.

Urologic nursing·2025
Same journal

Characteristics of Nursing Homes with High Rates of Urinary Tract Infections among Their Residents with Obesity.

Urologic nursing·2024
Same journal

Implementing a Multimodal Prehabilitation Program to Radical Cystectomy in a Comprehensive Cancer Center: A Pilot Study to Assess Feasibility and Outcomes.

Urologic nursing·2022
Same journal

Factors Affecting the Severity of Fatigue during Radiotherapy for Prostate Cancer; an Exploratory Study.

Urologic nursing·2021
Same journal

It's About Time: The Temporal Burden of Lower Urinary Tract Symptoms Among Women.

Urologic nursing·2021
Same journal

A Qualitative Study to Determine Barriers for Prostate Cancer Screening in Rural African-American Men.

Urologic nursing·2019
See all related articles

Related Experiment Video

Updated: May 25, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

A unique approach to severe constipation.

Shanna Atnip1, Joseph I Schaffer

  • 1Division of Urogynecology and Reconstructive Pelvic Surgery, Parkland Health and Hospital System, Dallas, TX, USA.

Urologic Nursing
|January 24, 2012
PubMed
Summary
This summary is machine-generated.

Sacral neuromodulation, used for bladder control, incidentally improved severe constipation in a patient who failed other treatments. This suggests a potential new therapeutic avenue for chronic constipation.

Related Experiment Videos

Last Updated: May 25, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Urology

Background:

  • Sacral neuromodulation (SNM) is an established treatment for overactive bladder symptoms.
  • SNM involves stimulating the sacral nerves to modulate neural activity.
  • Incidental normalization of bowel function has been observed in patients undergoing SNM for urinary conditions.

Observation:

  • A 48-year-old female patient presented with severe constipation.
  • The patient had exhausted all conservative treatment options without success.
  • She subsequently underwent sacral neuromodulation under nurse practitioner supervision.

Findings:

  • Following sacral neuromodulation, the patient experienced a return to normal defecatory function.
  • This outcome was achieved despite the SNM primarily targeting urinary dysfunction.

Implications:

  • Sacral neuromodulation may represent a novel therapeutic strategy for refractory constipation.
  • Further research is warranted to explore the mechanisms and efficacy of SNM for bowel disorders.
  • This highlights the interconnectedness of pelvic organ function and neural regulation.